首页 | 本学科首页   官方微博 | 高级检索  
     


Prolactin and zinc in dialysis patients
Authors:Castro Ana V B  Caramori Jacqueline  Barretti Pasqual  Baptistelli Elda E  Brandão Ambrósio  Barim Estela M  Padovani Carlos R  Aragon Flávio F  Brandão-Neto José
Affiliation:Unidade de Endocrinologia e Metabologia 1, Faculdade de Medicina, UNESP, Botucatu, S?o Paulo, Brazil.
Abstract:The objectives of the present study were to investigate the frequencies of hyperprolactinemia and hypozincemia in patients undergoing hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD), the associations between blood levels of zinc (Zn2+) and hormones, and dietary zinc intake amount and its relation to zincemia. We studied 28 patients (14 HD and 14 CAPD) who had their blood levels of Zn2+, prolactin (PRL), parathyroid hormone (PTH), and gonadotropins (LH, FSH) evaluated. Thirteen patients had dietary nutrient amounts evaluated from a 3-d nutritional record. Hyperprolactinemia occurred in 29% patients (HD = CAPD), hypozincemia in 62% (20% HD and 42% CAPD), and low dietary Zn2+ intake in 90% of patients. No correlation among blood concentration of Zn2+ and PRL, PTH, LH, and FSH were observed in the two modalities of dialysis or between zincemia and Zn2+ ingestion. We concluded that the occurrence of hyperprolactinemia and hypozincemia were not related to dialysis modality and that zincemia did not reflect the observed low dietary intake of Zn2+.
Keywords:Peritoneal dialysis  hemodialysis  prolactin  parathyroid hormone  luteinizing hormone  follicule-stimulating hormone  zinc
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号